Epstein-barr virus-induced gene-3 is expressed in human atheroma plaques.
Atherosclerosis is characterized by a complex immune response in the vessel wall, involving both inflammation and autoimmune processes. Epstein-Barr virus-induced gene 3 (Ebi3) is a member of the interleukin (IL)-12 heterodimeric cytokine family, which has important immunomodulatory functions. To date, little is known about the role of Ebi3 in vascular disease. We examined the expression of Ebi3 in human atheromatous lesions and analyzed its transcriptional regulation in vascular cells. The in situ expression of Ebi3 in human endarterectomy specimens was analyzed by immunohistochemistry. In these lesions, smooth muscle cells expressed Ebi3 as well as the IL-27alpha/p28 and IL-12alpha/p35 subunits. Primary aortic smooth muscle cells up-regulated Ebi3 in response to proinflammatory stimuli like tumor necrosis factor-alpha and interferon-gamma. Interestingly, pretreatment of these cells with the peroxisome proliferator-activated receptor-gamma agonist rosiglitazone strongly reduced Ebi3 induction. Chromatin immunoprecipitation experiments revealed that this inhibition is due to interference with p65/RelA recruitment to the Ebi3 promoter. Our data support a possible role of Ebi3 in atherogenesis either as homodimer or as IL-27/IL-35 heterodimer, and suggest that Ebi3 could be an interesting target for therapeutic manipulation in atherosclerosis.
Kempe
Sybille
S
Institute of Physiological Chemistry, Ulm University, Ulm, Germany.
Heinz
Philipp
P
Kokai
Enikö
E
Devergne
Odile
O
Marx
Nikolaus
N
Wirth
Thomas
T
D001011:Aorta / Q000378:metabolism; D050197:Atherosclerosis / Q000378:metabolism*; D016893:Carotid Stenosis / Q000378:metabolism*; D006801:Humans; D007004:Hypoglycemic Agents / Q000494:pharmacology; D007150:Immunohistochemistry; D047468:Immunoprecipitation; D007378:Interleukins / Q000096:biosynthesis*; D015778:Minor Histocompatibility Antigens; D032389:Myocytes, Smooth Muscle / Q000378:metabolism; D047495:PPAR gamma / Q000187:drug effects / Q000378:metabolism; D020133:Reverse Transcriptase Polymerase Chain Reaction; D000077154:Rosiglitazone; D045162:Thiazolidinediones / Q000494:pharmacology; D051996:Transcription Factor RelA / Q000187:drug effects / Q000378:metabolism; D015854:Up-Regulation
C097732:EBI3 protein, human; D007004:Hypoglycemic Agents; D007378:Interleukins; D015778:Minor Histocompatibility Antigens; D047495:PPAR gamma; D045162:Thiazolidinediones; D051996:Transcription Factor RelA; D000077154:Rosiglitazone